GlassScriptPhysician profile
Adam Eric Shestack
NPI 1588951974
$6,730.40
in general payments reported to CMS, 2019-2025
21 companies · $1,071 in 2025
The $1,071 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,328 · 2020: $199 · 2021: $541 · 2022: $841 · 2023: $744 · 2024: $1,008 · 2025: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,822.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $2,142.96 | 2019 | |
| Scilex Pharmaceuticals INC. | $1,069.62 | 2019-2024 | Ztlido |
| Boston Scientific Corporation | $951.58 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $891.29 | 2019-2025 | Eterna, Proclaim |
| Medtronic, INC. | $531.00 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Biotronik Nro, INC. | $382.50 | 2023-2025 | Prospera, Biotronik |
| Vertos Medical, INC. | $274.39 | 2023-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $207.62 | 2024-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $42.64 | 2023-2024 | Belbuca |
| Globus Medical, INC. | $32.49 | 2025 | Senza |
| Saluda Medical Americas, INC. | $24.82 | 2025 | Evoke |
| Redhill Biopharma INC. | $24.62 | 2021 | |
| Abbvie INC. | $23.86 | 2023 | Ubrelvy |
| Curonix LLC | $23.05 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kowa Pharmaceuticals America, INC. | $19.07 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $16.99 | 2024 | Senza |
| Almatica Pharma LLC | $16.27 | 2022 | |
| Protega Pharmaceutials INC | $15.75 | 2025 | Roxybond |
| Si-Bone, INC. | $13.92 | 2021 | |
| Hikma Pharmaceuticals USA | $13.32 | 2022 | |
| Medtronic USA, INC. | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Shestack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.